For its third fiscal quarter (ending September 30), USANA Health Sciences Inc (NYSE: USNA) has reported E.P.S. of $0.56 compared to $0.59 a year ago. E.P.S. were $2.84 for the latest four quarters through September 30 versus $3.10 for the same period a year ago.
Recent Price Action
On 10/22/24, USANA Health Sciences Inc (NYSE: USNA) stock declined modestly by -1.6%, closing at $34.48. Moreover, this decline was accompanied by unusually high trading volume at 150% of normal. The stock has been weak relative to the market over the last nine months and has declined -3.2% during the last week.
Current PriceTarget Research Rating
USNA is expected to continue to be a Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
USANA Health Sciences has a current Value Trend Rating of C (Low Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. USANA Health Sciences has a slightly positive Appreciation Score of 61 but a poor Power Rating of 30, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment